157 related articles for article (PubMed ID: 37965548)
1. Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis.
Huang XY; Zhang YH; Yi SY; Lei L; Ma T; Huang R; Yang L; Li ZM; Zhang D
Front Microbiol; 2023; 14():1217338. PubMed ID: 37965548
[TBL] [Abstract][Full Text] [Related]
2. Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?
Georgescu D; Ancusa OE; Azoulay D; Lascu A; Ionita I; Calamar-Popovici D; Ionita M; Rosca CI; Brează GM; Reisz D; Lighezan D
Int J Gen Med; 2023; 16():3889-3906. PubMed ID: 37662503
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
Lin GS; Xu Q; Zhao SY; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
[No Abstract] [Full Text] [Related]
4. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis.
Violi F; Pignatelli P; Castellani V; Carnevale R; Cammisotto V
Blood Rev; 2023 Jan; 57():100998. PubMed ID: 35985881
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
Ventura P; Venturelli G; Marcacci M; Fiorini M; Marchini S; Cuoghi C; Pietrangelo A
Thromb Res; 2016 May; 141():189-95. PubMed ID: 27065203
[TBL] [Abstract][Full Text] [Related]
6. Analysis of related factors of portal vein thrombosis in liver cirrhosis.
Xu X; Jin J; Liu Y; Li H
BMC Gastroenterol; 2023 Jan; 23(1):26. PubMed ID: 36717769
[TBL] [Abstract][Full Text] [Related]
7. Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis.
Matsui T; Usui M; Wada H; Iizawa Y; Kato H; Tanemura A; Murata Y; Kuriyama N; Kishiwada M; Mizuno S; Sakurai H; Isaji S
Clin Appl Thromb Hemost; 2018 Mar; 24(2):254-262. PubMed ID: 29050501
[TBL] [Abstract][Full Text] [Related]
8. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.
Giannitrapani L; Granà W; Licata A; Schiavone C; Montalto G; Soresi M
Med Princ Pract; 2018; 27(5):466-471. PubMed ID: 30107378
[TBL] [Abstract][Full Text] [Related]
9. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
10. [Correlational study on portal vein thrombosis of liver cirrhosis].
Xu DQ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jul; 28(7):573-579. PubMed ID: 32791792
[No Abstract] [Full Text] [Related]
11. Neutrophil extracellular traps are associated with enhanced procoagulant activity in liver cirrhosis patients with portal vein thrombosis.
Xing Y; Jiang Y; Xing S; Mao T; Guan G; Niu Q; Zhao X; Zhou J; Jing X
J Clin Lab Anal; 2022 May; 36(5):e24433. PubMed ID: 35435260
[TBL] [Abstract][Full Text] [Related]
12. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
Wosiewicz P; Żorniak M; Hartleb M; Barański K; Hartleb M; Onyszczuk M; Pilch-Kowalczyk J; Kyrcz-Krzemień S
Clin Res Hepatol Gastroenterol; 2016 Dec; 40(6):722-729. PubMed ID: 27160816
[TBL] [Abstract][Full Text] [Related]
13. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.
Xing Y; Tian Z; Jiang Y; Guan G; Niu Q; Sun X; Han R; Jing X
Ann Med; 2022 Dec; 54(1):302-309. PubMed ID: 35060835
[TBL] [Abstract][Full Text] [Related]
14. Composition and diversity of gut microbiota in diabetic retinopathy.
Bai J; Wan Z; Zhang Y; Wang T; Xue Y; Peng Q
Front Microbiol; 2022; 13():926926. PubMed ID: 36081798
[TBL] [Abstract][Full Text] [Related]
15. Correlation of routinely used coagulation parameters and presence of portal vein thrombosis in patients with liver cirrhosis.
Weber A; Krebs S; Lenhardt C; Wagenpfeil S; Schmid RM; Schulte-Frohlinde E
Hepatol Res; 2009 Sep; 39(9):882-7. PubMed ID: 19619258
[TBL] [Abstract][Full Text] [Related]
16. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
17. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study.
Liu X; Cheng YW; Shao L; Sun SH; Wu J; Song QH; Zou HS; Ling ZX
World J Gastroenterol; 2021 May; 27(19):2394-2414. PubMed ID: 34040330
[TBL] [Abstract][Full Text] [Related]
19. [Construction and validation of a nomogram for predicting the risk of portal vein thrombosis after splenectomy in patients with hepatitis B cirrhosis].
Xu W; Cheng Y; Tu B
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1265-1272. PubMed ID: 32990234
[TBL] [Abstract][Full Text] [Related]
20. Features of gut microbiota in patients with anorexia nervosa.
Yuan R; Yang L; Yao G; Geng S; Ge Q; Bo S; Li X
Chin Med J (Engl); 2022 Aug; 135(16):1993-2002. PubMed ID: 36191590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
